Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexagliflozin in Type 2 Diabetes
NCT01029704Phase 2Completed
- Sponsor
- Theracos, Inc.
- Start
- Dec 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bexagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Theracos, Inc.. Started Dec 2009; status: completed.
02
Drugs
bexagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01029704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01029704.